Cargando…

EPEN-12. COMPARING CELLULAR HIERARCHIES AND SPATIAL ARCHITECTURE ACROSS MOLECULAR SUBGROUPS OF SUPRATENTORIAL EPENDYMOMAS

Ependymomas (EPN) are among the most common and fatal pediatric brain tumors with currently no targeted therapies available. Molecular studies including genome-wide DNA methylation profiling have shown that supratentorial ependymoma is subdivided into subgroups characterized by distinct fusion prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Daeun, Maass, Kendra K, Ghasemi, David R, Englinger, Bernhard, Jiang, Li, Nascimento, Andrezza, Hack, Olivia A, Shaw, McKenzie L, Pfister, Stefan M, Kool, Marcel, Gojo, Johannes, Pajtler , Kristian W, Filbin , Mariella G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Final Category: Ependymoma - EPEN
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260098/ http://dx.doi.org/10.1093/neuonc/noad073.116

Ejemplares similares

EPEN-11. CHARACTERIZATION OF THE SPATIAL ARCHITECTURE OF INTRATUMORAL CELL STATES IN PEDIATRIC HIGH-RISK EPENDYMOMA
por: Bruckner, Katharina, et al.
Publicado: (2023)

EPEN-10. SPINAL EPENDYMOMA WITH MYCN-AMPLIFICATION – A DISEASE OF CHILDHOOD AND YOUNG ADULTHOOD WITH DISMAL PROGNOSIS
por: Ghasemi, David R, et al.
Publicado: (2023)

EPEN-13. PATTERN OF RELAPSE IN POSTERIOR FOSSA EPENDYMOMA GROUP A
por: Bajin, Inci Yaman, et al.
Publicado: (2023)

EPEN-02. OPTIMISING BIOMARKERS FOR ACCURATE EPENDYMOMA DIAGNOSIS, PROGNOSTICATION AND STRATIFICATION WITHIN INTERNATIONAL CLINICAL TRIALS: A BIOMECA STUDY
por: Chapman, Rebecca J, et al.
Publicado: (2023)

EPEN-01. ZFTA-RELA FUSION PROGRAMS CONVERGE ON YAP PATHWAY ACTIVATION IN EPENDYMOMA
por: Stuckert, Austin, et al.
Publicado: (2023)

EPEN-09. UTILITY OF RADIATION THERAPY IN SPINAL CORD MYXOPAPILLARY EPENDYMOMAS: A REVIEW OF THE LITERATURE
por: Jackson, Kasey, et al.
Publicado: (2023)

EPEN-04. DEVELOPMENT OF B7-H3-TARGETED CAR T CELL THERAPY FOR EPENDYMOMA
por: Mehta, Sanya, et al.
Publicado: (2023)

EPEN-05. TRANSCRIPTIONAL FACTOR-DIRECTED EPIGENETIC REGULATION IN CANCER NEUROSCIENCE OF ZFTA-RELA EPENDYMOMA
por: Chen, Hsiao-Chi, et al.
Publicado: (2023)

EPEN-06. CHARACTERISING THE DEVELOPMENTAL ORIGINS AND TRAJECTORIES OF ZFTA-RELA FUSION EPENDYMOMA IN A NOVEL MOUSE MODEL
por: Bonner, Sigourney, et al.
Publicado: (2023)

EPEN-08. COMBINED PDGFR INHIBITOR AXITINIB AND RETINOID TRETINOIN DECREASES PROLIFERATION AND HIGH-RISK NEOPLASTIC SUBPOPULATION PROPORTIONS PFA EPENDYMOMA
por: Donson, Andrew, et al.
Publicado: (2023)

EPEN-07. A MULTICENTER STUDY OF POOR PROGNOSIS CHROMOSOME 1Q GAIN AND/OR 6Q LOSS IN POSTERIOR FOSSA A EPENDYMOMA SHOWS INCREASED PREVALENCE FROM 20% AT DIAGNOSIS TO 60% AT FIRST RECURRENCE
por: Donson, Andrew, et al.
Publicado: (2023)

EPEN-44. EXTRACELLULAR VESICLES OF SUPRATENTORIAL EPENDYMOMA RELA MEDIATE INTERACTIONS WITH CELLS OF THE TUMOR MICROENVIRONMENT
por: Maass, Kendra K, et al.
Publicado: (2020)

EPEN-23. Interaction of epigenetic regulation and telomerase re-activation in high-risk ependymoma
por: Jaunecker, Carola N, et al.
Publicado: (2022)

EPEN-03. ZFTA/C11ORF95 FUSIONS DRIVE SUPRATENTORIAL EPENDYMOMA VIA SHARED ONCOGENIC MECHANISMS
por: Zheng, Tuyu, et al.
Publicado: (2021)

EPEN-03. ZFTA-RELA LOCALIZATION DYNAMICS REGULATE TRANSCRIPTIONAL CONTROL
por: Arabzade, Amir, et al.
Publicado: (2023)

EPEN-18. CROSS-SPECIES GENOMICS IDENTIFIES GLI2 AS AN ONCOGENE OF C11orf95 FUSION-POSITIVE SUPRATENTORIAL EPENDYMOMA
por: Zheng, Tuyu, et al.
Publicado: (2020)

EPEN-28. Oncogenic dependency of pediatric ependymomas on extracellular vesicle pathways
por: Maass, Kendra K, et al.
Publicado: (2022)

EPEN-21. IMPAIRED NEURONAL-GLIAL FATE SPECIFICATION IN PEDIATRIC EPENDYMOMA REVEALED BY SINGLE-CELL RNA-SEQ
por: Englinger, Bernhard, et al.
Publicado: (2020)

EPEN-47. PEDS: PEDIATRIC EPENDYMOMA DISCOVERY STUDY
por: Smith, Amy, et al.
Publicado: (2020)

EPEN-07. PATTERNS OF EXTRANEURAL METASTASES IN PEDIATRIC SUPRATENTORIAL EPENDYMOMA: CASE SERIES AND REVIEW OF THE LITERATURE
por: Chan, Priya P, et al.
Publicado: (2020)

EPEN-03. USP7 is an interaction partner of EZHIP and potential druggable target in PFA ependymomas
por: Jenseit, Anne, et al.
Publicado: (2022)

EPEN-53. C11orf95-RELA REPROGRAMS 3D EPIGENOME IN SUPRATENTORIAL EPENDYMOMA
por: Zhu, Jacqueline Jufen, et al.
Publicado: (2020)

EPEN-06. CHEMOTHERAPY OF RECURRENT EPENDYMOMA: LONG-TERM RESPONSE ONLY IN FEW CASES
por: Adolph, Jonas, et al.
Publicado: (2020)

EPEN-01. MULTIDISCIPLINARY TREATMENT IN EPENDYMOMA
por: Hirokawa, Daisuke
Publicado: (2020)

EPEN-01. C11ORF95-RELA DICTATES ONCOGENIC TRANSCRIPTIONAL PROGRAMS TO DRIVE AGGRESSIVE SUPRATENTORIAL EPENDYMOMA
por: Arabzade, Amir, et al.
Publicado: (2021)

EPEN-04. ONCOGENIC 3D TUMOR GENOME ORGANIZATION IDENTIFIES NEW THERAPEUTIC TARGETS IN EPENDYMOMA
por: Okonechnikov, Konstantin, et al.
Publicado: (2020)

EPEN-27. CDKN2A DELETION IN SUPRATENTORIAL EPENDYMOMA WITH RELA ALTERATION INDICATES A DISMAL PROGNOSIS – A RETROSPECTIVE ANALYSIS OF THE HIT EPENDYMOMA TRIAL COHORT
por: Jünger, Stephanie T, et al.
Publicado: (2020)

EPEN-18. Oncogenic 3D genome conformations identify novel therapeutic targets in ependymoma
por: Okonechnikov, Konstantin, et al.
Publicado: (2022)

EPEN-03. LONG-TERM FOLLOW-UP OF AIEOP 2ND SERIES OF CHILDREN AND ADOLESCENT WITH PRIMARY INTRACRANIAL (ST:SUPRATENTORIAL; PF: POSTERIOR FOSSA) EPENDYMOMA AND METHYLATION GROUPS RE-ANALYSES
por: Massimino, Maura, et al.
Publicado: (2020)

EPEN-14. GENERATION OF A C11orf95-RELA FUSION TARGETING ANTIBODY AS A DIAGNOSTIC TOOL FOR SUPRATENTORIAL EPENDYMOMA
por: Ruff, Lisa, et al.
Publicado: (2020)

EPEN-25. EXCEPTIONAL CLINICAL AND IMAGING RESPONSE TO TRK-INHIBITION IN A PATIENT WITH SUPRATENTORIAL EPENDYMOMA HARBORING NTRK2 GENE FUSION
por: Mangum, Ross, et al.
Publicado: (2020)

EPEN-05. Adenosine receptor expression in paediatric ependymoma
por: Spanoudakis, Chelsea, et al.
Publicado: (2022)

EPEN-16. TRANSCRIPTIONAL REGULATORY CIRCUITRIES AS MOLECULAR TARGETS IN EPENDYMOMA
por: Bertrand, Kelsey, et al.
Publicado: (2020)

EPEN-24. SIOP EPENDYMOMA II: CENTRAL EPENDYMOMA MANAGEMENT ADVISORY GROUP – THE UK EXPERIENCE
por: Macarthur, Donald C, et al.
Publicado: (2020)

EPEN-24. Biological markers of ependymoma in children and adolescents (BIOMECA): Systematic comparison of methods for the precise evaluation of biomarkers for ependymoma diagnosis and prognostication
por: Chapman, Rebecca, et al.
Publicado: (2022)

EPEN-36. THE TREATMENT OUTCOME OF PAEDIATRIC SUPRATENTORIAL C11ORF95-RELA FUSED EPENDYMOMA: A COMBINED REPORT FROM E-HIT SERIES AND AUSTRALIAN NEW ZEALAND CHILDREN’S HAEMATOLOGY/ONCOLOGY GROUP
por: Ng, Chia Huan, et al.
Publicado: (2020)

EPEN-35. PERITONEAL CARCINOMATOSIS OF ANAPLASTIC EPENDYMOMA: FIRST REPORTED CASE
por: Schwartz, Jonathan, et al.
Publicado: (2020)

EPEN-52. METABOLIC REGULATION OF THE EPIGENOME DRIVES LETHAL INFANTILE EPENDYMOMA
por: Kumar, Sachin, et al.
Publicado: (2020)

EPEN-37. TREATMENT OUTCOME OF RECURRENT EPENDYMOMA IN CHILDREN IN NORTHERN EGYPT
por: Fadel, Shady, et al.
Publicado: (2020)

EPEN-45. NORMALIZING AND FACILITATING GENOMIC TESTING AT DIAGNOSIS IN PEDIATRIC EPENDYMOMA
por: Pickle, Emily Owens, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4n7bg0e595usdti0s1gsao02t6